Brief report
Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension

https://doi.org/10.1016/0002-9149(83)90678-1Get rights and content

References (6)

There are more references available in the full text version of this article.

Cited by (131)

  • Outcomes of atrial septostomy and effect on long-term survival in patients with idiopathic pulmonary arterial hypertension: A single-center cohort

    2023, International Journal of Cardiology
    Citation Excerpt :

    As these procedures are complex and associated with high risk, including substantial procedure-related mortality, they may only be considered in centres with experience in the techniques [3,14]. Since the first report of septostomy in PAH 30 years ago [15], BAS is used to alleviate RHF symptoms and/or syncope [7,16]. Despite the use and purported benefits of BAS [17,18], it remains a palliative and invasive therapy.

  • Left Ventricular Decompression in VA-ECMO: Analysis of Techniques and Outcomes

    2022, Journal of Cardiothoracic and Vascular Anesthesia
  • Lung Transplantation for Pulmonary Hypertension

    2021, Encyclopedia of Respiratory Medicine, Second Edition
  • Interventional Therapies in Pulmonary Hypertension

    2018, Revista Espanola de Cardiologia
View all citing articles on Scopus
View full text